Antonio Omuro

7PUBLICATIONS
66CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Deep learning
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 27, 2023
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma.

Kristina Fanucci, Mary Jo Pilat, Derek Shyr

|Aug 17, 2022
Immune-checkpoint inhibitors for glioblastoma: what have we learned?

Antonio Omuro

|Apr 01, 2022
Machine Learning in Differentiating Gliomas from Primary CNS Lymphomas: A Systematic Review, Reporting Quality, and Risk of Bias Assessment.

G I Cassinelli Petersen, J Shatalov, T Verma

|Mar 10, 2022
Using Adversarial Images to Assess the Robustness of Deep Learning Models Trained on Diagnostic Images in Oncology.

Marina Z Joel, Sachin Umrao, Enoch Chang

Pageof 2